Timings:

• 00:00 — Intro
• 00:58 — Welcome, and what the MHRA actually does
• 02:33 — Balancing patient safety against innovation and access
• 05:46 — How the MHRA's medical and scientific assessors work with pharma and biotech
• 08:07 — The new weight-loss pill: why the UK approved it first
• 12:00 — Brexit's impact on approval speed and the UK's standing globally
• 12:34 — Covid, budget cuts, and how the MHRA fell behind, then caught up
• 15:10 — Lawrence's mother's cancer diagnosis and the clinical trial that gave her 12 more years
• 16:55 — Why patients struggle to find and stay in the right clinical trials
• 20:47 — Bringing patients into the research process, not just researching on them
• 21:08 — How the MHRA can use approval as a lever to demand diversity in trials
• 22:04 — The gender gap in clinical trial participation
• 23:25 — Ethnicity, Covid vaccine hesitancy, and representative research
• 25:29 — Checking for diverse trial populations before granting a licence
• 27:22 — Does industry see this as a barrier to getting drugs to market?
• 29:03 — Closing thoughts and the road ahead
• 29:50 — The football referee analogy: what the MHRA is really there to do

My Health Focus is not a medical service. The information provided is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment.

JOIN THE MY HEALTH FOCUS COMMUNITY AND SIGN UP TO OUR NEWSLETTER

Hosted on Acast. See acast.com/privacy for more information.